Vaxcyte, Inc.
PCVX
$59.67
-$0.69-1.14%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -70.68% | -127.85% | -79.83% | -106.38% | -29.42% |
| Total Depreciation and Amortization | 18.78% | 20.11% | 104.81% | 15.72% | 43.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 572.39% | 94.15% | 35.07% | 270.34% | -42.13% |
| Change in Net Operating Assets | -98.00% | 94.12% | -692.88% | 9.79% | 532.32% |
| Cash from Operations | -91.86% | -68.77% | -101.82% | -136.06% | 0.19% |
| Capital Expenditure | 53.11% | 44.70% | 71.96% | 68.37% | 74.97% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 74.06% | -245.68% | 123.44% | 115.16% | 311.21% |
| Cash from Investing | 90.01% | -289.28% | 120.66% | 113.21% | 196.69% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 139.91% | 9,998.83% | -43.01% | -99.98% | -97.08% |
| Repurchase of Common Stock | -187.31% | -75.71% | 7.19% | 57.40% | -26.90% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 126.41% | 79,159.95% | -50.93% | -100.24% | -97.72% |
| Foreign Exchange rate Adjustments | 74.63% | -156.66% | -86.96% | 105.22% | 156.74% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -93.62% | 311.78% | 83.83% | -104.80% | 56.80% |